Global Veterinary Infectious Diseases Therapeutics Market Overview
Veterinary infectious diseases are the diseases that can get transmitted from one animal to another animal or into a human being. The demand of livestock is high in dairy, poultry, textiles and other industries. Veterinary infectious diseases can affect reproduction and neonatal period in livestock. Thus, the demand for the animals to be healthy is high. Safety and quality are the major concerns of the livestock industry to serve to the human population. Hence, a threat to the veterinary industry is a risk for the human population as well. As per the data of United States Department of Agriculture, U.S alone produced more than 212 billion pounds of milk in 2016. Huge amount of meat and poultry are also recovered from these livestock industries. This large amount of livestock products recovery requires healthy animal. But the infectious diseases in the animals do not allow the easy flow of livestock industry. Hence veterinary infectious diseases therapeutics was introduced for comparatively smoother work flow of the livestock industry.
Market Size & Forecast
Veterinary Infectious Diseases Therapeutics Market is anticipated to record a significant CAGR over the forecast period. The veterinary infectious diseases therapeutics market is estimated to propel due to increasing demand of livestock products owing to ever increasing human population worldwide. One of the key factors playing in market expansion for veterinary infectious disease therapeutics is the rising cognizance among people about the zoonotic diseases and their propagation. Advancements in the veterinary infectious disease therapeutics technology are also expanding the boundaries of the market. There is a huge variety of drugs that can be used as anti-infective for animals including specific drugs for diseases like malaria and tuberculosis. Government measures that try to improve the condition and well-being of animals are further anticipated to help in the veterinary infectious diseases therapeutics market growth.
On the basis of regional platform, global veterinary infectious diseases therapeutics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Aspects such as the presence of strong economic growth, superior animal health care provisions, rising trend of pet ownership, and higher emphasis on the prevention of diseases by veterinarians and owners are key to North America’s supremacy in the global veterinary infectious diseases therapeutics market. The trend of companion animals in the region is increasing due to factors such as the rising pet population. Introduction of new products by global players furthermore aids in maintaining the region’s lead.
Asia-Pacific and Europe is expected to be the most lucrative regions for veterinary infectious diseases therapeutics market owing to the rising population and hence the demand for healthy livestock and pet animals. Latin America is predicted to arise as one of the foremost meat exporters in the world over the course of the next few years. Hence, market vendors are investing in the region to cope the possible rise in demand for vaccines, drugs, and medicated feed additives for the future.
Get more information on this report: Download Sample PDF
Market Segmentation
Our-in depth analysis of the global veterinary infectious diseases therapeutics market includes the following segments:
By Drug-Type
- Antibiotics
- Antiviral
- Antifungal
- Amebicides
- Anthelmintics
By End-User
- Veterinary hospitals
- Veterinary Clinics
- Veterinary pharmacies
- Research institutes
By Region
Global veterinary infectious diseases therapeutics market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
Veterinary infectious disease therapeutics market growth is affected by the growing awareness about the spread of various zoonotic diseases amongst the existing population. The major factors that behave as the key factors to drive the growth of veterinary infectious disease therapeutics market are the increasing demand for dairy, meat and poultry products due to the ever rising population size and better standards of living. Government initiatives to guarantee food safety are also accountable for the growth of veterinary infectious disease therapeutics market growth. The increase in the number of government associations or other non-profit organizations that work for the well-being of animals are as well predicted to drive the market for veterinary infectious disease therapeutics.
However, one factor that restricts the growth of veterinary infectious disease therapeutics market is the lower number of veterinarians in the under-developed or developing nations. The major restraint that the veterinary infectious disease therapeutics market is expected to face is the dearth of knowledge in the developing countries about animal health issues.
Top Featured Companies Dominating The Market
- Elanco Animal Health
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis Animal Health Inc.
- Merck & Co. Inc.
- Pfizer Animal Health
- Sanofi
- Boehringer Ingelheim Vetmedica
- Dechra Animal Health
- Ceva Sante Animale
- Elanco Animal Health
- Virbac S.A.
